One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...
In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary ...
Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...
1don MSN
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...
Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...
Home-based HIV counseling and relationship building improved HIV testing, diagnoses and viral suppression among pregnant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback